Leading Wall Street Analysts Positively Assess Growth Potential of These 3 Stocks
Global markets face pressure due to concerns surrounding AI and higher oil prices
Insurer UnitedHealth reported better-than-expected third-quarter results, and Morgan Stanley analyst Erin Wright maintained a 'Buy' recommendation with a $529 target price. The company raised its annual profit forecast, which Wright believes reflects improvements in UnitedHealthcare and Optum Health performance, as well as progress in its business recovery plan.
Guggenheim analyst Michael Morris raised the target price for Meta Platforms shares to $850 while keeping the 'Buy' recommendation. He links investor expectations to the performance of the AI agent Muse ahead of the quarterly report and believes the company will initially focus more on expanding its audience than monetization. According to his assessment, the primary revenue model may be based on companies paying for access to consumers through their agents, which aligns with integrations with Shopify and PayPal.
Stifel analyst Tore Svanberg reaffirmed a 'Buy' recommendation for Marvell Technology shares with a $370 target price. At the Investor Day, the company increased its addressable market estimate to $400 billion, citing AI-related demand. Management expects a balanced mix of XPU and XPU Attach segments in the Custom business, while suppliers have confirmed their readiness to support Marvell's expanded capacity plans.
